Irbesartan in patients with atrial fibrillation

The ACTIVE I Investigators

Research output: Contribution to journalArticlepeer-review

202 Citations (Scopus)

Abstract

Irbesartan did not reduce cardiovascular events in patients with atrial fibrillation. (Funded by Bristol-Myers Squibb and Sanofi-Aventis; ClinicalTrials.gov number, NCT00249795.).
Original languageEnglish
Pages (from-to)928-938
Number of pages11
JournalNew England Journal of Medicine
Volume364
Issue number10
DOIs
Publication statusPublished - 2011

Cite this